Skip to main content
Equibles
NEO logo

NEO · Neogenomics Inc

Track NEO — free

Use NEO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NEO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$15.94 -0.45 (-2.75%) At close · Aug 14
Market Cap
$2.08B
Shares
130.21M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$15.94 Open$16.38 Day$15.89–16.40 52W close$6.10–16.63 Avg vol 30d2.7M Short int15.4M · 11.8% float · 4.2d Short vol68% Last earningsJul 28, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 27, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 28, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +43%
      above
      Price vs 50-day avg +15%
      above
      RSI (14) 58
      neutral
      MACD trend Negative
      52-week position 93%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +9%
      trailing
      6-month return +60%
      trailing
      YTD return +36%
      this year
      Relative strength +46%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $14 › 200d $11 — 50d above 200d
      Institutional flow Accumulating
      +4% holders QoQ · +57 funds added
      Insider flow Distributing
      Net -$321.4K over 90 days · 100% sells
      Short interest Rising
      11.84% of float · ▲ +12.0% MoM · 4.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      265 holders — mid 3-yr range
      Squeeze score 77
      high risk · 0–100
      Fundamentals
      Weak
      Revenue growth +10%
      Y/Y
      Gross margin 43%
      contracting
      EPS growth −300%
      Y/Y
      Free cash flow $-21.8M
      Balance sheet $182.2M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 59%
      annualized · 1-yr
      Max drawdown −46%
      past year
      ATR 4.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 2 of last 2
      Latest guidance · from the 8-K filed Jul 28, 2026
      Consolidated revenue · Updated FY 2026 Guidance $802M – $806M
      Net loss · Updated FY 2026 Guidance $-42M – $-34M
      Adjusted EBITDA · Updated FY 2026 Guidance $56M – $58M
      Prior guidance period ended · from the 8-K filed Jan 12, 2026
      Total revenue · fourth quarter of 2025 $190M
      Total revenue · full-year 2025 $727M
      Guided vs delivered · last 2 settled
      Revenues full year 2024
      guided $650M – $660M
      $660.57M Beat +0.8%
      Revenue Q1 '24
      guided $148M – $151M
      $156.24M Beat +4.5%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +43% Bullish
      Price vs 50-day avg
      +15% Bullish
      RSI (14)
      58 Neutral
      MACD trend
      Negative Bearish
      52-week position
      93% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $14 › 200d $11 — 50d above 200d
      Institutional flow Accumulating
      +4% holders QoQ · +57 funds added
      Insider flow Distributing
      Net -$321.4K over 90 days · 100% sells
      Short interest Rising
      11.84% of float · ▲ +12.0% MoM · 4.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      265 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $6 Now $16 · 93% Range high $17
      vs 200-day avg +43% vs 50-day avg +15%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Diagnostics & Research — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      NEO
      Neogenomics Inc
      this stock
      		$2.08B +35.5% +10.1% — 11.8%
      TMO
      Thermo Fisher Scientific Inc.
      		 $217.52B +1.5% +14.5% 31.7 1.3%
      DHR
      Danaher Corp /De/
      		 $142.32B -11.6% +8.5% 35.9 1.7%
      NTRA
      Natera, Inc.
      		 $44.67B +35.3% -2.8% — 3.0%
      IDXX
      Idexx Laboratories Inc /De
      		 $43.41B -18.6% +10.4% 38.7 2.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      265
      % held
      118.3%
      Net QoQ
      +19.0M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      258
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      15.4M
      Days to cover
      4.2d
      Change
      +1.7M sh
      View
      Short Volume
      Short vol %
      68%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.9K
      Value
      $27.5K
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      43.0%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$321.4K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Gilbert Cisneros
      Amount
      $1.0K–$15.0K
      Traded
      May 7, 2025
      View
      Financials
      Financials
      Net income (FY)
      $-108.0M
      EPS diluted
      $-0.04
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 11, 2026
      This year
      17
      View
      Proposed Sales
      Value
      $321.5K
      Shares
      20.0K
      Filed
      Aug 4, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 28, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      NEO -3.8% +9.1% +59.9% +4.3% +35.5%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -4.2% +4.7% +46.1% +0.3% +21.7%
      Key facts CIK 1077183 CUSIP 64049M209 13F (30d) 246 filings 244 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)